A combination of dual PI3K-mTOR inhibitor, GDC-0980, with PARP inhibitor plus carboplatin blocked tumor growth of BRCA-competent triple-negative breast cancer cells.
Nandini Dey
No relevant relationships to disclose
Yuliang Sun
No relevant relationships to disclose
Jennifer Carlson
No relevant relationships to disclose
Lori Friedman
Employment or Leadership Position - Genentech
Stock Ownership - Roche
Pradip De
No relevant relationships to disclose
Brian Leyland-Jones
No relevant relationships to disclose